About: Natalizumab: a country-based surveillance program

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Natalizumab: a country-based surveillance program Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2008 (uk) im September 2008 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56992576-522BF8E1-716D-4D29-9CA9-467B00977647
publication date	2008-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56992576-6063E040-33CF-4FAD-8041-735F778F6DEC
language of work or name	English
exact match	wds:Q56992576-E005524C-6CCE-4AFB-A775-04ADE9EE2F98
exact match	https://scigraph.springernature.com/pub.10.1007/s10072-008-0948-8
cites work	wds:Q56992576-1B0DA523-F2C5-4568-BE37-7A1A2FCE6DF3 wds:Q56992576-1FACA8B4-5B1F-4360-92CB-5C6DEA08F644 wds:Q56992576-A3675DBE-303A-4029-AE4A-8AC28C69AB2D wds:Q56992576-B47272B9-05EE-42D9-993B-28D115772F5B wds:Q56992576-B63D2146-539B-4642-B5A9-19A2BE3C6E44 wds:Q56992576-C5052DC7-28A2-4595-AC36-431FA3445950 wds:Q56992576-C86C6DF5-F4CF-4DDA-9D36-DCEAB0D4186F wds:Q56992576-DC6DE750-5822-4882-9D65-1FD22EF9BCA1 wds:Q56992576-E73CEF91-8603-4AA9-9240-B9CA4FC42BB7 wds:Q56992576-EFB5AA9E-50AF-4C20-85A8-F5C1812A130C
cites work	A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis Natalizumab plus interferon beta-1a for relapsing multiple sclerosis A controlled trial of natalizumab for relapsing multiple sclerosis. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
author name string	wds:Q56992576-2B84B62A-2647-4CBB-A6D2-1D496152F478 wds:Q56992576-2C7FDFD9-9E18-4F6B-B543-18B828AF8A20 wds:Q56992576-338D7C92-A543-4E3D-8374-333FE09034F1 wds:Q56992576-45CA8774-B18E-40DB-8677-6E74FEF3C431 wds:Q56992576-6F19EFAF-6755-4339-AB3B-A30BD4AEAFE6 wds:Q56992576-83D86A32-B061-4605-99C0-0CA1BC5D592D wds:Q56992576-92CF97AF-36A3-43B8-B00E-E28426B32E02 wds:Q56992576-9688E92F-1EC1-4B5F-A6D8-83F1800C4755 wds:Q56992576-A58D745A-4C7E-4D1E-A491-EB94EDA39C61 wds:Q56992576-CF4954EF-23D6-47C7-823F-5530A3E9BF81 wds:Q56992576-D4625A3E-EE91-4308-ACF5-9EF41DAD4E0C wds:Q56992576-DCDB458D-2C3D-4AA0-BD14-00411CAA3475
author name string	Leandro Provinciali Gian Luigi Mancardi Maria Rosaria Tola Nicola Montanaro Patrizia Popoli Roberto D'Alessandro Laura Periotto Nello Martini Anna Covezzoli Marisa De Rosa Clara Milanese Pasqualino Rossi
rdfs:label	Natalizumab: a country-based surveillance program (en) Natalizumab: a country-based surveillance program (nl)
skos:prefLabel	Natalizumab: a country-based surveillance program (en) Natalizumab: a country-based surveillance program (nl)
name	Natalizumab: a country-based surveillance program (en) Natalizumab: a country-based surveillance program (nl)
author	wds:Q56992576-1FCCBD17-E570-4D29-BFB4-71B5E4432A91 wds:Q56992576-65E67075-F970-46D7-A750-42E08998B1DD wds:Q56992576-74E4A7DF-C1D3-487D-8BD0-AA38C4EAEF6F wds:Q56992576-768FFE80-02FC-46A2-ACD5-6C0F85F9FE79 wds:Q56992576-D5DAD7C8-517B-4548-AE07-10B3EF03E932 wds:Q56992576-E39E5BF0-DE60-49F5-9E25-2C357575F1B7 wds:Q56992576-F90C317D-B9EC-495C-8AA3-D1623AAE28CB
author	Filippo Drago Maria Pia Amato Gioacchino Tedeschi Nicola Vanacore Giovanni Savettieri Carlo Piccinni Antonio Addis
title	wds:Q56992576-4AE97E79-99A4-4552-9EB2-1E06D9440EC2
title	Natalizumab: a country-based surveillance program (en)
page(s)	wds:Q56992576-4DAEF214-B403-4DCA-835A-123B7E335CE5
page(s)	S235-7
instance of	wds:Q56992576-44FD8D5E-820D-45AE-A391-7D46E26375C4
instance of	scholarly article
PubMed ID	wds:Q56992576-E1D9FEDB-985D-4DCD-AE1C-90F55FAD5870
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18690503
PubMed ID	18690503
published in	wds:Q56992576-06C2CA90-4A68-40F0-9851-374009CCB957
published in	Neurological Sciences
volume	wds:Q56992576-8B402778-3D68-43E3-9C97-2E0565CC62BD
volume	29 Suppl 2
DOI	wds:Q56992576-D10679BA-51D0-488C-A971-52D08C64D28B
DOI	http://dx.doi.org/10.1007/S10072-008-0948-8
DOI	10.1007/S10072-008-0948-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56992576
is cites work of	A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study Three years of experience: the Italian registry and safety data update. Clinical baseline factors predict response to natalizumab: their usefulness in patient selection Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
is cites work of	wds:Q43881574-6C8B71AC-71F4-4B5E-9D6E-303AF634667E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software